| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case report of typhlitis during novel use of ropidoxuridine–capecitabine–radiotherapy for treatment-naïve rectal cancer
|
Kunos, Charles A.
|
|
|
92 |
2 |
p. 151-155
|
artikel
|
| 2 |
Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study
|
Någård, Mats
|
|
|
92 |
2 |
p. 141-150
|
artikel
|
| 3 |
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
|
Piha-Paul, Sarina A.
|
|
|
92 |
2 |
p. 107-118
|
artikel
|
| 4 |
Influence of age on pharmacokinetics of capecitabine and its metabolites in older adults with cancer: a pilot study
|
Shafiei, Mohsen
|
|
|
92 |
2 |
p. 135-139
|
artikel
|
| 5 |
Osthole inhibits malignant phenotypes and induces ferroptosis in KRAS-mutant colorectal cancer cells via suppressing AMPK/Akt signaling
|
Zhou, Xinghua
|
|
|
92 |
2 |
p. 119-134
|
artikel
|
| 6 |
Pharmacology and pharmacokinetics of elacestrant
|
Beumer, Jan H.
|
|
|
92 |
2 |
p. 157-163
|
artikel
|
| 7 |
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies
|
Boulter, Alexis C.
|
|
|
92 |
2 |
p. 97-105
|
artikel
|
| 8 |
The role of alternative splicing in lung cancer
|
Ning, Xuelian
|
|
|
92 |
2 |
p. 83-95
|
artikel
|
Tijdschrift beschrijving